| Literature DB >> 33920180 |
Silvana Alfei1, Barbara Marengo2, Giulia Elda Valenti2, Cinzia Domenicotti2.
Abstract
Drug resistance is a multifactorial phenomenon that limits tEntities:
Keywords: ROS damage; antimicrobial cationic polymers; chemoresistance; human neuroblastoma cells
Year: 2021 PMID: 33920180 PMCID: PMC8069339 DOI: 10.3390/nano11040977
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Scheme 1Structure of antibacterial cationic copolymer P5 and synthetic procedure performed to prepare it [4].
Scheme 2Synthesis of monomer M7 (7).
Scheme 3Reaction scheme of copolymerization of M7 with dimethylacrylamide (DMAA) to obtained P7.
Experimental data for the copolymerization of M7 and M5 [4].
| Cationic Monomer | DMAA | Solvent | AIBN | Time | Copolymers |
|---|---|---|---|---|---|
| M7 | 560.0, 5.63 | MeOH | 13.4, 1.7 | 72 | P7 |
| M5 [ | 765.9, 7.7 | DMF | 15.3, 1.0 | 7 | P5 [ |
1 loading (%) of cationic monomer; 2 percentage wt/wt (monomers + DMAA); 3 percentage of conversion.
Figure 1Significant part of FTIR spectrum of P7.
Data of calibration, results of measurements and estimation of Mn of P7 according to Equation (2). Data of calibration, results of measurements, and estimation of Mn of the copolymer P5, previously reported, are included for comparison purposes [4].
| Copolymer | Calibration | Measurements | ||
|---|---|---|---|---|
|
|
|
|
|
|
| 0.0048410 | 856 | 13.8525 | 13,719 | |
| 0.0058304 | 930 | 23.9796 | ||
| 0.0068966 | 1007 | 30.5577 | ||
|
|
| |||
|
|
|
|
| |
| 0.0048410 | 856 | 2.1949 | 5100 | |
| 0.0058304 | 930 | 5.6195 | ||
| 0.0068966 | 1007 | 7.7859 | ||
|
|
| |||
Results of volumetric titration of an exactly weighted amount of P7 and P5 [4]. Hydrodynamic size (nm), ζ-p, and PDI at 37 °C of P7 and P5 [4] by DLS analysis (degree of freedom n = 3).
| Copolymer | mg (mmol) | HClO4 0.1612 N | NH2
| µequiv.NH2/g | µequiv.NH2/µmol |
|---|---|---|---|---|---|
|
| 350.1 (0.0255) | 0.66 | 0.1067 | 305 | 4.2 |
| 300.5 (0.0589) | 1.67 | 0.2686 | 894 | 4.6 | |
|
|
|
|
| ||
|
| 3 | 220 ± 18 | +49.8 ± 5.8 | 0.809 ± 0.004 | |
| 3 | 334 ± 27 | +57.6 ± 1.7 | 1.012 ± 0.007 | ||
1 Mn of P7, 2 Mn of P5.
Data of potentiometric titrations of P5 and P7 used to construct the titration curves (Figure 2a) and computed values of dpH/dV used to construct the relative first derivative curves (Figure 2b). The last three rows report the max values of dpH/dV computed for P5 and P7 and the corresponding values of HCL 0.1 N volumes and of pH.
| mL HCl 0.1 N | pH (P5) | pH (P7) | dpH/dV (P5) | dpH/dV (P7) |
|---|---|---|---|---|
| 0.0 | 9.34 | 9.54 | ||
| 0.2 | 9.20 | 9.30 | 0.7 | 1.2 |
| 0.4 | 9.00 | 9.00 | 1 | 1.5 |
| 0.6 | 8.80 | 6.85 | 1 | 10.75 |
| 0.8 | 7.20 | 6.15 | 8 | 3.5 |
| 1.0 | 7.00 | 5.60 | 1 | 2.75 |
| 1.2 | 4.60 | 4.80 | 12 | 4 |
| 1.4 | 4.50 | 4.65 | 0.5 | 0.75 |
| 1.6 | 4.40 | 4.50 | 0.5 | 0.75 |
| 1.8 | 4.30 | 4.45 | 0.5 | 0.25 |
| 2.0 | 4.30 | 4.40 | 0 | 0.25 |
| 2.2 | 4.30 | 4.35 | 0 | 0.25 |
| 2.4 | 4.30 | 4.30 | 0 | 025 |
| 2.6 | 4.30 | 4.30 | 0 | 0 |
| 2.8 | 4.30 | 4.20 | 0 | 0.5 |
| 3.0 | 4.30 | 4.15 | 0 | 0.25 |
|
|
| |||
| Max dpH/dV | 12 | 4.5 | 10.75 | 4 |
| HCl (mL) | 0.8 | 1.2 | 0.6 | 1.2 |
| pH | 6.40 | 5.20 | 6.85 | 4.80 |
Figure 2Titration curves of P5 and P7 (a); first derivatives lines of the titration curves (b).
Max β values and βave of P5, P7, and commercial polyethyleneimine (PEI-b) in the pH range 4.5–7.5 computed from potentiometric titrations data.
| Entry | β (pH Value) | βave * (mL/pH) |
|---|---|---|
| P5 | 0.667 (6.10) | 0.2305 ± 0.1354 |
| P7 | 1.33 (4.65) | 0.3500 ± 0.2293 |
| PEI- | 0.08261 (7.33) | 0.517 ± 0.2541 |
* Defined as the volume of HCl 0.1N necessary to decrease the pH by 1 unit in the pH range 4.5–7.5 and is reported as mean ± SD (n = 3).
Figure 3Buffer capacity curves of PEI-b 25 kD alone (a); buffer capacity curves of P5, P7, and PEI-b 25 kD (b).
Figure 4Average buffer capacity of P5, P7 and PEI-b 25 kD.
Values of LD50 computed for monomers M5 and M7 and for copolymers P5 and P7, considering the results obtained by dose-dependent cytotoxic essays.
| M5 | P5 | M7 | P7 | |
|---|---|---|---|---|
| LD50 (µM) | LD50 (µM) | LD50 (µM) | LD50 (µM) | |
| HTLA | 250 | 4.3 | 100 | 5.1 |
| ER | 250 | 2.2 | 100 | 4.1 |
Figure 5Cell viability was evaluated by CellTiter 96® AQueous One Solution Cell Proliferation Assay in HTLA-230 (HTLA, a) and HTLA-ER (ER, b) cells exposed to increasing concentrations of P5 (0–10 μM) for 24 h. Bar graphs summarize quantitative data of the means ± SEM of three independent experiments. ** p < 0.01 vs. Ctr cells.
Figure 6Dispersion graphs of the viability of NB cell populations exposed to increasing concentration of P5 (0–10 μM) for 24 h (a); linear regressions associated with the dispersion graphs of the viability of HTLA-230 cells (HTLA) up to 5 µM and of HTLA-ER (ER) cells up to 2.5 µM (b).
Figure 7Cell viability was evaluated by CellTiter 96® AQueous One Solution Cell Proliferation Assay in HTLA-230 (HTLA, a) and HTLA-ER (ER, b) cells exposed to increasing concentration of P7 (0–10 μM) for 24 h. Bar graphs summarize quantitative data of the means ± SEM of three independent experiments. ** p < 0.01 vs. Ctr cells.
Figure 8Dispersion graphs of the viability of HTLA-230 (HTLA) and HTLA-ER (ER) cells exposed to increasing concentration of P7 (0–10 μM) for 24 h (a); linear regressions associated with the dispersion graphs of the viability up to 5 µM for both NB cells populations (b).
Figure 9Reactive oxygen species (ROS) generation was analyzed in HTLA-230 (HTLA, a) and HTLA-ER (ER, b) cells exposed to increasing concentrations (0–10 µM) of P5 for 24 h. Bar graphs summarize quantitative data of the means ± SEM of three independent experiments. ** p < 0.01 vs. Ctr cells.
Figure 10ROS generation was analyzed in HTLA (a) and ER (b) NB cells exposed to increasing concentrations (0–10 µM) of P7 for 24 h. Bar graphs summarize quantitative data of the means ± SEM of three independent experiments. ** p < 0.05 vs. Ctr cells.